Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-05-29 @ 8:20 PM
Study NCT ID:
NCT04924192
Status:
UNKNOWN
Last Update Posted:
2021-09-21
First Post:
2021-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TQB3616-ALTN-II-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None